Becker's Healthcare November 9, 2021
Katie Adams

Private insurers and cash-paying patients face prices several times higher than the Medicare rate for clinician-administered drugs, according to a study published Nov. 8 in JAMA Internal Medicine.

Researchers searched the websites of the 20 top-rated hospitals by U.S. News & World Report for drug pricing files between Jan. 1 and Sept. 15, extracting private insurer-negotiated prices and self-pay cash prices for the 10 drugs with the highest 2019 Medicare Part B expenditures.

Median prices for the 10 drugs surpassed the Medicare payment limit by a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Healthcare System, Insurance, Medicare, Patient / Consumer, Payer, Pricing / Spending, Provider, Survey / Study, Trends
Related Articles:
FDA launches initiative to advance home healthcare models, devices
HHS releases national suicide prevention strategy, plan
A new kind of gene-edited pig kidney was just transplanted into a person
Patient Engagement Is Essential for Achieving the Goals of Value-Based Care
U.S. expands testing for bird flu in dairy cows

Share This Article